216. 両大血管右室起始症 Disease details / Clinical trials / Drug dev / DR info /
臨床試験数 : 1 / 薬物数 : 7 - (DrugBank : 1) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 14
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Cardiac MRI
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
Echocardiogram
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
N-thymidine
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
Physical exam
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
Propranolol hydrochloride
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
Specimen collection
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
Urine collection
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
Echocardiogram
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
N-thymidine
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
Physical exam
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
Propranolol hydrochloride
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
Specimen collection
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States
Urine collection
Weill Medical College of Cornell University
2022 Phase 1 NCT04713657 United States